New medications come to market after passing rigorous clinical trials. Trials provide the scientific evidence that the new drugs work as intended – and that they are safe. But modern clinical trials are complex and fragmented: Researchers are spread across continents, across technology platforms and across native languages – all of which can slow the trial process to a frustrating crawl.

Now i3, the global pharmaceutical services arm of Ingenix, is ready to help bring greater efficiency to the clinical trial process.

Meet the i3Cube™; it's the first clinical trial management system to automate the entire trial process from beginning to end. The i3Cube system supports far-flung clinical trials by connecting study sponsors, investigative site staff and i3 personnel to deliver a shared view of trial processes and results that have not been available until now. Responding to today's global development environment, i3Cube provides a local language end-user experience in English, French, German and Japanese.

Clinical experts in the global pharmaceutical services arm of Ingenix worked with technology industry leaders like Adobe^® to help research teams coordinate their activities like never before. The i3Cube system drives shorter timelines, lower costs, better collaboration, and greater team efficiencies – and that means faster access to better medicine for everyone.

It was recently announced that i3Cube won the 2009 Adobe MAX Award. The annual Adobe MAX Awards recognize the best uses of Adobe software around the globe. MAX Award winners pioneer the use of new and existing technologies that redefine traditional approaches to work. As this year's Enterprise Productivity Adobe MAX award winner, the i3Cube system solidifies our standing as a highly innovative technology company, dedicated to the needs of our customers and our industry.

Back to Innovations from UnitedHealthcare